| Phase 2 Extension Trial in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) (NCT01226745) | EMD Serono | 2010-10-01 |
| Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS) (NCT01381354) | University of Iowa | 2010-10-01 |
| The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients (NCT01005095) | Carmel Medical Center | 2010-10-01 |
| JC Virus Reactivation in Multiple Sclerosis (NCT02004444) | Beth Israel Deaconess Medical Center | 2010-10-01 |
| Zoledronic Acid in MS-patients With Osteoporosis (NCT01166178) | Novartis | 2010-10-01 |
| Extension Study to Evaluate Safety and Efficacy of Natalizumab in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (NCT01416155) | Biogen | 2010-10-01 |
| Safety Study of BIIB033 in Subjects With Multiple Sclerosis (NCT01244139) | Biogen | 2010-10-01 |
| Cytotron® Delivered Rotational Field Quantum Nuclear Magnetic Resonance Therapy for Multiple Sclerosis (NCT01220830) | The Centre for Advanced Research & Development, India | 2010-09-01 |
| JC-virus (JCV) Epidemiology in Multiple Sclerosis (MS) (NCT01185717) | Biogen | 2010-09-01 |
| Balance Training for People With Multiple Sclerosis Using Nintendo Wii Fit (NCT01299025) | Örebro County Council | 2010-09-01 |
| Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe) (NCT01212094) | National Institute of Neurological Disorders and Stroke (NINDS) | 2010-09-01 |
| Experimental Evaluation of Wheelchair-Mounted Robotic Arms (NCT01652352) | University of South Florida | 2010-08-01 |
| Evaluation of Angioplasty in the Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis (NCT01201707) | Community Care Physicians, P.C. | 2010-08-01 |
| Responsiveness to Dalfampridine-ER Treatment Among Multiple Sclerosis Patients (NCT01399957) | Mount Sinai Rehabilitation Hospital | 2010-08-01 |
| Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis (NCT00997438) | Portland VA Medical Center | 2010-08-01 |
| Study To Evaluate Treating Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis Patients (NCT01089686) | Manish Mehta, MD | 2010-08-01 |
| Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients (NCT01167426) | Teva Neuroscience, Inc. | 2010-07-01 |
| REsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis Patients (NCT01171209) | Melinda Magyari | 2010-07-01 |
| Retrospective Cohort Study of Rebif® Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY) (NCT01207648) | EMD Serono | 2010-07-01 |
| Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis (NCT01219647) | University of California, Los Angeles | 2010-07-01 |
| Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial (NCT01085318) | EMD Serono | 2010-06-30 |
| Combined Sensitivity and Specificity of Cortical Lesions and Central Vein Sign for MS Diagnosis and Differential Diagnosis (NCT04369898) | University Hospital, Basel, Switzerland | 2010-06-01 |
| Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE (NCT01450072) | State University of New York at Buffalo | 2010-06-01 |
| The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort (NCT01723709) | Duke University | 2010-06-01 |
| Measuring Signatures in the Fluid Surrounding the Spinal Cord in Patients Who Have Problems With Intrathecal Drug Delivery (NCT01117090) | MedtronicNeuro | 2010-06-01 |
| Influence of Emotional Disorders and Executive on the Components Retrograde and Anterograde Episodic Memory in MS (NCT02518776) | University Hospital, Caen | 2010-06-01 |
| Pharmacogenomics of Drug Safety in Multiple Sclerosis (NCT01118130) | University of British Columbia | 2010-06-01 |
| Controlled High Risk AVONEX® Multiple Sclerosis Prevention Study In Ongoing Neurological Surveillance (NCT01156298) | Biogen | 2010-06-01 |
| Prospective Randomized Endovascular Therapy in Multiple Sclerosis (NCT05380362) | University at Buffalo | 2010-06-01 |
| BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis (NCT01156311) | Biogen | 2010-06-01 |
| Efficacy of L-carnitine Versus Placebo in the Treatment of Fatigue in Multiple Sclerosis (NCT01149525) | University Hospital, Bordeaux | 2010-06-01 |
| GSK2018682 FTIH in Healthy Volunteers (NCT01387217) | GlaxoSmithKline | 2010-05-21 |
| Investigating Mechanism of Action of DAC HYP in the Treatment of High-Inflammatory Multiple Sclerosis (MS) (NCT01143441) | National Institute of Neurological Disorders and Stroke (NINDS) | 2010-05-13 |
| Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis (NCT01093326) | Actelion | 2010-05-12 |
| The Efficacy of EMDR in Patients With PTSD in Multiple Sclerosis (NCT01743664) | San Luigi Gonzaga Hospital | 2010-05-01 |
| Depression and Fatigue in MS Patients Treated With Betaferon. (NCT01354665) | Bayer | 2010-05-01 |
| Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis (NCT01122056) | University of British Columbia | 2010-05-01 |
| Prospective, Multicenter Non Interventional Study to Evaluate Adherence to Betaferon Over a 2 Years Period (NCT01076595) | Bayer | 2010-05-01 |
| Visual Reconstitution Therapy After Optic Neuritis (NCT01274702) | Friedemann Paul | 2010-05-01 |
| Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis (NCT01071512) | University of Chicago | 2010-04-01 |
| Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS) (NCT01181115) | Biogen | 2010-04-01 |
| Study of Alternative Exercise Therapies for Progressive Multiple Sclerosis (MS) (NCT01097538) | Hicks, Audrey, Ph.D. | 2010-04-01 |
| Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis (NCT01024777) | Johns Hopkins University | 2010-03-01 |
| Improving Gait in Multiple Sclerosis (MS) - Strength Training or Treadmill Walking? (NCT01074827) | St. Olavs Hospital | 2010-03-01 |
| JC-Virus (JCV) Antibody Program (NCT01070823) | Biogen | 2010-03-01 |
| Pharmacogenetic Trial and Long-term Follow-up of the PRISMS Trial (PRISMS-15) (NCT01034644) | Merck KGaA, Darmstadt, Germany | 2010-03-01 |
| Endovascular Treatment for Chronic Cerebrospinal Venous Insufficiency (CCSVI) (NCT01264848) | Euromedic Specialist Clinics, Poland | 2010-03-01 |
| A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (NCT01081782) | Ono Pharma USA Inc | 2010-03-01 |
| Impact Study of 2 Therapeutic Strategy for Aggressive Remitting Multiple Sclerosis (NCT01065727) | Rennes University Hospital | 2010-03-01 |
| A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis (NCT01144351) | Elan Pharmaceuticals | 2010-03-01 |
| NOGO-A in Multiple Sclerosis FTIH (NCT01424423) | GlaxoSmithKline | 2010-02-11 |
| Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort (NCT01070719) | John F. Foley, MD | 2010-02-01 |
| The Effects of Ethyl-Alpha-Guanido-Methyl Ethanoate on Skin Reactions From Glatiramer Acetate Injections (NCT00988988) | University of Nebraska | 2010-02-01 |
| Improving Hand Use in Multiple Sclerosis (NCT01081275) | National Multiple Sclerosis Society | 2010-02-01 |
| Repetitive Deep Transcranial Magnetic Stimulation in Multiple Sclerosis (NCT01106365) | Charite University, Berlin, Germany | 2010-02-01 |
| Neuroprotection and Repair in Optic Neuritis (NCT01073813) | University of Calgary | 2010-02-01 |
| Effect of an Internet-based At-home Physical Training Protocol on Quality of Life, Fatigue, Functional Performance, Aerobic Capacity and Muscle Strength in Multiple Sclerosis Patients (NCT02771652) | University of Erlangen-Nürnberg | 2010-02-01 |
| Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting. (NCT01101776) | Merck KGaA, Darmstadt, Germany | 2010-01-01 |
| Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial. (NCT01031459) | Bayer | 2010-01-01 |
| A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study (NCT01036165) | EMD Serono | 2010-01-01 |
| Clinical Isolation Syndrome of Spinal Cord and Multiple Sclerosis (NCT04952246) | Peking University Third Hospital | 2010-01-01 |
| Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis (NCT01214317) | Isfahan University of Medical Sciences | 2010-01-01 |
| Robot-based Rehabilitation of Upper Limb Impairment in Multiple Sclerosis (NCT02711566) | Fondazione Don Carlo Gnocchi ETS | 2010-01-01 |
| Novel Immune Markers in Patients With Multiple Sclerosis (NCT01026272) | University of Washington | 2010-01-01 |
| Study Evaluating Betaferons Safety and Tolerability In Pediatric Patients With Multiple Sclerosis (NCT00963833) | Bayer | 2009-12-17 |
| Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative Diseases (NCT01954875) | Wake Forest University Health Sciences | 2009-12-02 |
| Evaluation of Sloan-Charts for Assessment of Disease Progress in Multiple Sclerosis (NCT01272596) | Charite University, Berlin, Germany | 2009-12-01 |
| The Role of Serum Leptin Levels in Multiple Sclerosis Disease Activity While on Interferon Beta 1a (Rebif) Treatment (NCT01067573) | University of South Florida | 2009-12-01 |
| Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS) (NCT00986960) | University at Buffalo | 2009-12-01 |
| Effects of Vaporized Marijuana on Neuropathic Pain (NCT01037088) | University of California, Davis | 2009-12-01 |
| Safety and Dose-finding Study of DC-TAB in Healthy Subjects (NCT02442557) | Delta Crystallon BV | 2009-12-01 |
| Efficacy of Clean Intermittent Catheterization (CIC) in Multiple Sclerosis (MS) Patients With Bladder Dysfunction (NCT00913510) | Wellspect HealthCare | 2009-12-01 |
| Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants Who Have Participated in Cladribine Clinical Trials (NCT01013350) | EMD Serono | 2009-11-30 |
| Study of Lisdexamfetamine Sulfate to Treat Cognitive Dysfunction in Multiple Sclerosis (NCT01615887) | State University of New York at Buffalo | 2009-11-01 |
| Reducing Symptoms of Multiple Sclerosis Using Non-invasive Neuromodulation (NCT04498039) | University of Wisconsin, Madison | 2009-11-01 |
| Pulse ACTH vs. MP for MS (NCT01049451) | University of Southern California | 2009-11-01 |
| A Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 µg 3 Times Weekly (NCT01198132) | Merck KGaA, Darmstadt, Germany | 2009-11-01 |
| Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions (NCT01028209) | Institute for Neurodegenerative Disorders | 2009-11-01 |
| The Multicenter, Open-label, Single-use Autoinjector Convenience Study (NCT00958009) | EMD Serono | 2009-10-01 |
| Telehealth-Based Exercise Program to Treat Fatigue in MS (NCT01198977) | VA Office of Research and Development | 2009-10-01 |
| TakeCharge: Telephone Delivered Self-management Intervention for People With Multiple Sclerosis (MS) (NCT00944190) | University of Washington | 2009-10-01 |
| Motivational Interviewing to Increase Physical Activity to Treat Depression in People Aging With MS or SCI (NCT00947232) | University of Washington | 2009-10-01 |
| Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis (NCT01006265) | Actelion | 2009-10-01 |
| Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone (NCT00947895) | Neurologique Foundation, Inc. | 2009-10-01 |
| Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Oct (NCT01024985) | University of Sao Paulo | 2009-09-01 |
| Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS) (NCT00910598) | Amphia Hospital | 2009-09-01 |
| Telephone Intervention for Pain Study (TIPS) (NCT00663663) | University of Washington | 2009-09-01 |
| Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis (MS) (NCT00981084) | University of Missouri, Kansas City | 2009-09-01 |
| Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological Conditions (NCT00970333) | Institute for Neurodegenerative Disorders | 2009-08-01 |
| Treatment Adherence When Using RebiSmart™ in Relapsing Multiple Sclerosis Subjects (NCT01128075) | Merck KGaA, Darmstadt, Germany | 2009-08-01 |
| Vitamin D3 Supplementation and the T Cell Compartment in Multiple Sclerosis (MS) (NCT00940719) | Maastricht University Medical Center | 2009-08-01 |
| Assessment of Patient Use of a New Device: RebiSmart (NCT01195870) | Merck KGaA, Darmstadt, Germany | 2009-07-01 |
| Rajavtihi Neuronal Adult Stem Cells Project (NCT00927108) | Department of Medical Services Ministry of Public Health of Thailand | 2009-07-01 |
| Escitalopram (Lexapro) for Depression MS or ALS (NCT00965497) | University of South Carolina | 2009-07-01 |
| Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple Sclerosis (NCT00972062) | University of North Carolina, Charlotte | 2009-06-01 |
| Biomarkers and Response to Natalizumab for Multiple Sclerosis Treatment (NCT00942214) | University Hospital, Toulouse | 2009-06-01 |
| Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus (NCT00799942) | Merz Pharmaceuticals GmbH | 2009-05-01 |
| Sunphenon in Progressive Forms of Multiple Sclerosis (NCT00799890) | Friedemann Paul | 2009-05-01 |
| Modeling and Treating the Pathophysiology of Demyelination in Multiple Sclerosis (NCT00854750) | Elliot Frohman | 2009-05-01 |
| A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis (NCT00914290) | Impax Laboratories, LLC | 2009-04-01 |